Press Release – updated: Mar 14, 2018 06:00 EDT
ROCHESTER, NY, March 14, 2018 – â€‹â€‹â€‹Tens of thousands of adults in upstate New York are gambling with their health by choosing not to be screened for colon cancer, according to research findings issued today by Excellus BlueCross BlueShield. Among those adults who are not screened, only one in four report that a doctor or health professional has recommended that they be tested for colon cancer. Colon cancer is the second-leading cause of cancer death among adults in the United States.
â€œEach year in upstate New York, 2,300 people are diagnosed with colon cancer,â€� says Gregory Carnevale, M.D., Excellus BCBS chief medical officer for value based payments. â€œUpstate New York averages 800 deaths a year from the disease.”
Regular screenings can detect early-stage colon cancer before symptoms develop. Early detection is important because treatments are more likely to be successful for early- rather than late-stage cancer.
“There is need for the whole health care system to become involved in promoting the importance of colon cancer screening.”
Gregory Carnevale, M.D.
Excellus BCBS chief medical officer for value based payments
â€œA recommendation from a provider is a powerful factor in a patientâ€™s decision to be screened for cancer,â€� said Carnevale. â€œHowever, increasing colon cancer screening rates is not just a task for providers. There is need for the whole health care system to become involved in promoting the importance of colon cancer screening.â€�
Colonoscopy is the most thorough screening test and is proven to prevent the disease. Removing benign or pre-cancerous polyps during colonoscopy can not only prevent colon cancer, but also reduce deaths from the disease for years, according to the National Institutes of Health.
Colon cancer screening is recommended every ten years for all adults ages 50 to 75. Individuals who have colon cancer risk factors, including a family history of colon cancer, or previous polyps, may need to have their first screening at a younger age, and/or more frequently.
Excellus BCBS pledged its support for the National Colorectal Cancer Roundtableâ€™s â€œ80% by 2018â€� goal of having 80 percent of adults aged 50 and older screened for colorectal cancer by 2018. Currently, about one-third of upstate New York adults in the 50- to 75-year-old age range have not been screened.
The NCCRT was founded in 1997 by the American Cancer Society and the Centers for Disease Control and Prevention. If achieved, the screening goal of â€œ80% by 2018â€� would prevent 277,000 cases of colorectal cancer, and 203,000 associated deaths by 2030.
â€œColon cancer screening is covered in full as an â€˜essential benefitâ€™ of all health insurance, so thereâ€™s really no excuse for not getting screened, and it can save your life!â€� says Carnevale.
Excellus BlueCross BlueShield, a nonprofit independent licensee of the BlueCross BlueShield Association, is part of a family of companies that finances and delivers vital health care services to about 1.5 million people across upstate New York. Excellus BlueCross BlueShield provides access to high-quality, affordable health coverage, including valuable health-related resources that our members use every day, such as cost-saving prescription drug discounts and wellness tracking tools. To learn more, visit ExcellusBCBS.com.
Source: Excellus BlueCross BlueShield
Latest posts by Jasmine Petters (see all)
- Dental Implants Market to Attain a Value of US $6.54 Billion by 2025 - March 22, 2018
- High Pressure Processing Equipment Market to Reap over US$ 133.5 Million in Revenues by End of 2026 - March 22, 2018
- New Report Focusing on IoT Fleet Management Market Expanding at CAGR of +20% by 2025: Regulative Landscape, Newly Invented Strategies, Statistical Investigation - March 22, 2018